Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Healthcare CIOs are shifting from AI deployment to AI governance

Healthcare executives are focusing more on the governance of AI technologies rather than just their deployment. Ensuring AI models remain accurate, accountable, and trusted is becoming the new challenge for technology leaders in health systems.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Artificial IntelligenceHealthcare ItClinical Decision SupportAi Governance
Share
Learn this in 60 seconds

Key facts, context, and what it means, in one minute.

:60
0:001:00
Healthcare CIOs are shifting from AI deployment to AI governance

Key takeaways

01

AI governance is becoming more crucial than just deployment in healthcare technology.

02

Maintaining accuracy and accountability in AI models is a primary concern for healthcare CIOs.

03

Trust in AI systems is essential for their successful integration into healthcare.

AI deployment is no longer the hard part for health system technology leaders. Keeping AI accurate, transparent, and trusted by clinicians once it goes live, that is the operational problem dominating conversations among CIOs and chief digital officers in 2026, according to a series of reports by Healthcare IT News.

The pattern is consistent across organizations of varying size and complexity. CommonSpirit Health, Hartford HealthCare, Beth Israel Lahey Health, Children's Minnesota, and Optum Health are among the named health systems reporting that their AI programs have moved well past the pilot phase, and are now confronting the harder governance and sustainability questions that follow.

Governance has overtaken deployment as the primary concern

Inflo Health's Angela Adams, as quoted by Healthcare IT News, frames the shift directly: success in AI depends less on deploying new models than on governing existing ones. That view is widely shared. Across reported cases, health systems are finding that AI tools can enter clinical workflows quickly, but accountability structures, who owns model outcomes, how errors get flagged, and what happens when a model drifts, lag behind.

Generative AI hallucinations are driving some of this urgency. Healthcare IT News reports that CIOs are reworking validation and trust frameworks as a direct response to discovering that generative tools can produce plausible but incorrect clinical outputs. The challenge is not catching errors before go-live; it is building the monitoring infrastructure to catch them continuously after.

Lior Eshel of TestDynamics, cited by Healthcare IT News, describes the problem as one of sustained accuracy: deploying a model is a one-time event, but ensuring it remains reliable in a changing clinical environment is an ongoing operational commitment.

Data architecture is the prerequisite most organizations skip

Several technology leaders are pointing to foundational data infrastructure as the variable that separates high-performing AI programs from stalled ones. Robert Slepin, Chief Digital Officer at SE Health, told Healthcare IT News that organizations managing their data with the same discipline applied to financial assets will be better prepared for trustworthy AI. The implication for procurement and IT operations teams is concrete: AI vendor evaluation cannot happen in isolation from an honest assessment of the organization's data quality and governance maturity.

Lukasz Lazewski of LLInformatics, as reported by Healthcare IT News, reinforces this point directly: the organizations most likely to scale AI successfully are those that invest first in architecture, governance, and interoperability, not those that move fastest to deploy the newest models.

Children's Minnesota CIO Dave Lundal told Healthcare IT News he believes AI will ultimately surpass the EHR transition in operational significance, and that health systems need to build governance, vision, and flexibility now, before the pace of change makes catch-up nearly impossible.

Workflow integration and clinician trust are separating pilots from production

Ambient AI documentation tools have reached meaningful adoption at several health systems, with Beth Israel Lahey Health reporting dramatic reductions in documentation burden as a result, according to Healthcare IT News. But the next challenge, as ModMed's Daniel Cane describes it, is connecting AI across the full care workflow, prior authorizations, referrals, payer compliance, and claims management, rather than treating ambient documentation as an end point.

Hartford HealthCare has integrated PatientGPT into its patient portal and clinical infrastructure, a deployment that pairs AI-powered patient guidance with physician oversight and data governance controls, per Healthcare IT News. The approach reflects a broader design principle: AI-facing systems need human accountability layers built in from the start, not added later.

CommonSpirit Health's Chief Medical Informatics Officer, cited by Healthcare IT News, describes AI's most immediate value as scaling cancer screening, identifying findings that clinicians might otherwise miss while reducing administrative burden. The framing is notably cautious: AI amplifies clinical capacity rather than replacing clinical judgment.

Autonomous AI in clinical decisions: interest with guardrails

Healthcare IT News reports that technology and clinical leaders hold widely varying views on autonomous AI decision-making. The emerging consensus, per reporting by Bill Siwicki, is that the future of AI in medicine depends less on model performance than on accountability and clinician trust. Autonomous capability may be technically achievable in some domains; whether health systems can govern it responsibly is a separate question entirely.

Research from Duke University Health System, reported by Healthcare IT News writer Andrea Fox, offers a concrete warning on adoption durability: many AI-enabled clinical decision support tools see usage decline after initial uptake. The finding points to a design and change-management problem, not just a technology one. AI tools that care teams cannot clearly evaluate, explain, or trust tend to fall out of routine use.

Optum Health's phased rollout of AI-powered chart summarization, reported by Healthcare IT News, illustrates one approach to avoiding that pattern: introduce tools incrementally, measure administrative burden reduction at each stage, and use real workflow data to guide broader scaling decisions. The rollout is ongoing in 2026.

What this means for your team

  • Audit your data governance maturity before expanding AI vendor contracts. Multiple health system CIOs report that weak data foundations are the primary factor limiting AI reliability, not model capability.
  • Build model monitoring into every AI procurement requirement. Ask vendors specifically how their tools detect and surface accuracy degradation after go-live, not just before.
  • Evaluate AI tools for workflow continuity, not just point-of-care performance. Leaders at ModMed and Hartford HealthCare indicate that tools siloed within a single workflow stage deliver significantly less value than those connected across authorization, documentation, and billing.
  • Treat clinician trust as a measurable adoption metric. Duke University Health System research shows that AI-enabled decision support tools lose traction without ongoing visibility into how and why they make recommendations.

Featured companies

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS launches dedicated health technology office as AI and interoperability pressure mounts on hospital IT teams

CMS launches dedicated health technology office as AI and interoperability pressure mounts on hospital IT teams

The Centers for Medicare & Medicaid Services (CMS) have established a new Office of Health Technology and Products. This office aims to integrate AI, promote interoperability, and advance digital health strategies, thereby increasing demands on hospital IT teams.

  • 01CMS has launched an Office of Health Technology and Products to focus on AI, interoperability, and digital health strategy.
  • 02The new CMS office will increase demands and expectations on hospital IT teams.
  • 03Improving interoperability and integrating AI in healthcare is a crucial priority for CMS.

Jul 18, 2026

Medical device supply chains face persistent pressure as federal glove push falls short

Medical device supply chains face persistent pressure as federal glove push falls short

The medical device supply chain is under sustained pressure due to various factors including domestic glove manufacturing failures and product shortages in hospitals. Additionally, there is intense competition in the $1.5 billion heart valve market. These challenges are causing shifts in medtech supply signals.

  • 01The medical device supply chain is experiencing continued stress due to manufacturing failures and shortages.
  • 02Domestic glove manufacturing efforts have not met expectations, contributing to supply chain issues.
  • 03The heart valve market faces increased competition valued at $1.5 billion.

Jul 18, 2026

From Chaos to Control: Dr. Mo Canellas on AI, Emergency Medicine & Why Most “AI Companies” Fake It

From Chaos to Control: Dr. Mo Canellas on AI, Emergency Medicine & Why Most “AI Companies” Fake It

Dr. Maureen 'Mo' Canellas discusses the implementation of AI in emergency medicine and critiques the authenticity of many companies claiming to be AI-focused. She highlights her roles at UMass Memorial Medical Center and collaborations with institutions like MIT. Dr. Canellas also contributes to discussions around health care operations and benchmarking.

  • 01Dr. Mo Canellas is a significant figure in emergency medicine, focusing on machine learning and healthcare operations.
  • 02Many companies claiming to focus on AI in healthcare do not genuinely implement such technology.
  • 03Dr. Canellas collaborates with MIT and the Emergency Department Benchmarking Alliance for health care research and advancement.

Jul 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512